The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 27, 2018

Filed:

Aug. 25, 2016
Applicant:

Ajinomoto Co., Inc., Tokyo, JP;

Inventors:

Tomoyuki Mine, Kanagawa, JP;

Naoki Hayashi, Kanagawa, JP;

Itaru Kon, Kanagawa, JP;

Kazunori Saima, Kanagawa, JP;

Assignee:

AJINOMOTO CO., INC., Tokyo, JP;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A23L 33/12 (2016.01); A61K 31/07 (2006.01); A61K 31/198 (2006.01); A61K 31/20 (2006.01); A61K 31/202 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/4415 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/714 (2006.01); A61K 33/04 (2006.01); A61K 33/30 (2006.01); A61K 38/05 (2006.01); A23L 2/52 (2006.01); A23L 33/115 (2016.01); A23L 33/15 (2016.01); A23L 33/155 (2016.01); A23L 33/17 (2016.01); A23L 33/175 (2016.01); A23L 33/18 (2016.01);
U.S. Cl.
CPC ...
A23L 33/12 (2016.08); A23L 2/52 (2013.01); A23L 33/115 (2016.08); A23L 33/15 (2016.08); A23L 33/155 (2016.08); A23L 33/17 (2016.08); A23L 33/175 (2016.08); A23L 33/18 (2016.08); A61K 31/07 (2013.01); A61K 31/198 (2013.01); A61K 31/20 (2013.01); A61K 31/202 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4415 (2013.01); A61K 31/51 (2013.01); A61K 31/525 (2013.01); A61K 31/714 (2013.01); A61K 33/04 (2013.01); A61K 33/30 (2013.01); A61K 38/05 (2013.01); A23V 2002/00 (2013.01);
Abstract

A nutritional composition is provided which has an effective prophylactic and/or improving effect for various symptoms of muscle mass decrease, decreased basal metabolism, low body temperature, suppression of obesity, suppression of visceral fat accumulation, hyperglycemia, hyperlipidemia and the like in elderly people. The nutritional composition can include n-3 fatty acid and one or more of free lysine, dipeptides containing lysine, and lysine salts, wherein the content of free lysine, dipeptides containing lysine, and/or lysine salts is 0.1 g-10.0 g per 100 kcal of the composition, and the content of the total amount of n-3 fatty acid is 0.17 g-5.00 g per 100 kcal of the composition.


Find Patent Forward Citations

Loading…